Current concepts in neurocritical care

Anesthesiology Clinics of North America

Volumn 20, Issue 2, 2002, Pages 441-462

  Fahy, Brenda G ^a   Sivaraman, Vadivelu ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN INJURY; CEREBROVASCULAR ACCIDENT; EMERGENCY; HUMAN; REVIEW; SPINAL CORD INJURY; SUBARACHNOID HEMORRHAGE; BLOOD PRESSURE MONITORING; BRAIN HEMORRHAGE; BRAIN VASOSPASM; CEREBROSPINAL FLUID DRAINAGE; CLINICAL TRIAL; DEEP VEIN THROMBOSIS; EARLY DIAGNOSIS; FIBRINOLYTIC THERAPY; HYPERTENSION; HYPOTENSION; INTENSIVE CARE; INTRACRANIAL HYPERTENSION; KIDNEY FAILURE; LUNG EDEMA; PATIENT MONITORING; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRACTICE GUIDELINE; SCORING SYSTEM; SEIZURE; STROKE; TREATMENT INDICATION;

BRAIN INJURIES; CEREBROVASCULAR ACCIDENT; EMERGENCIES; HUMANS; SPINAL CORD INJURIES; SUBARACHNOID HEMORRHAGE; HUMAN;

ALTEPLASE; ANTIBIOTIC AGENT; ANTIHYPERTENSIVE AGENT; BARBITURIC ACID DERIVATIVE; CALCIUM ANTAGONIST; DANAPAROID; DIAZEPAM; DIURETIC AGENT; EBSELEN; FIBRINOLYTIC AGENT; GANGLIOSIDE GM1; GLYCERYL TRINITRATE; HEPARIN; LABETALOL; LOW MOLECULAR WEIGHT HEPARIN; MANNITOL; METHYLPREDNISOLONE; NICARDIPINE; NIMODIPINE; NITROPRUSSIDE SODIUM; OSMOTIC DIURETIC AGENT; PHENYTOIN; TIRILAZAD; VASODILATOR AGENT;

EID: 0036312638     PISSN: 08898537     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8537(01)00011-6     Document Type: Review

References (97)

1. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke
2. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke
3. Differential effect of aspirin versus warfarin on clinical stroke types in patients with atrial fibrillation
4. Grades of recommendation for antithrombotic agents
5. Sonographic monitoring of midline shift in hemispheric infarctions
6. Prevention of venous thromboembolism
7. Timing for fever-related brain damage in acute ischemic stroke
8. Guidelines for the management of aneurysmal subarachnoid hemorrhage. A statement for healthcare professionals from a special writing group of the Stroke Council
9. The International Cooperative Study on the timing of aneurysm surgery. Part 1: Overall management results
10. Aneurysmal rebleeding: A preliminary report from the Cooperative Aneurysm Study
11. Early operation and overall outcome in aneurysmal subarachnoid hemorrhage
12. Antifibrinolytic therapy for aneurysmal subarachnoid haemorrhage
13. Antifibrinolytic treatment in subarachnoid hemorrhage: A randomized placebo-controlled trial
14. The effect of continuous drainage of cerebrospinal fluid in patients with subbarachnoid hemorrhage: A retrospective analysis of 108 patients
15. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computed tomographic scanning
16. In vivo animal models of cerebral vasospasm: A review
17. Vasospasmogenic substance produced following subarachnoid haemorrhage, and its fate
18. A review of hemoglobin and the pathogenesis of cerebral vasospasm
19. Time course of vasospasm in man
20. Management of subarachnoid hemorrhage in the critical care unit
21. Impairment of cerebral autoregulation during the development of chronic cerebral vasospasm after subarachnoid hemorrhage in primates
22. Hypovolemia in patients with subarachnoid hemorrhage: Therapeutic implications
23. Depression of circulating blood volume in patients after subarachnoid hemorrhage: Implications for the management of symptomatic vasospasm
24. Control of hypertension and prophylaxis against vasospasm in cases of subarachnoid hemorrhage: A preliminary report
25. Clinical vasospasm after subarachnoid hemorrhage: Response to hypervolemic hemodilution and arterial hypertension
26. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension
27. Cardiac performance indices during hypervolemia therapy for cerebral vasospasm
28. Complications of Swan-Ganz catheterization for hemodynamic monitoring in patients with subarachnoid hemorrhage
29. Efficacy of prophylactic nimodipine for delayed ischemic deficit after subarachnoid hemorrhage: A meta-analysis
30. A randomized trial of two doses of nicardipine in aneurysmal subarachnoid hemorrhage: A report of the Cooperative Aneurysm Study
31. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial
32. A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage
33. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm
34. Effect of the 21-aminosteroid U-74006F on cerebral vasospasm following subarachnoid hemorrhage
35. Randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in Europe, Australia, and New Zealand
36. A randomized, double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: A cooperative study in North America
37. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part I. A cooperative study in Europe, Australia, New Zealand, and South Africa
38. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. Part II. A cooperative study in North America
39. Effects of a hydroxyl radical scavenger on delayed ischemic neurological deficits following aneurysmal subarachnoid hemorrhage: Results of a multicenter, placebo-controlled double-blind trial
40. Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage
41. Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: Initial observations regarding the use of intraventricular sodium nitroprusside in humans
42. Medical complications of aneurysmal subarachnoid hemorrhage: A report of the multicenter, cooperative aneurysm study
43. One-year outcome in early aneurysm surgery: A 14 year experience
44. Cardiologic complications of subarachnoid hemorrhage
45. Myocardial injury and left ventricular performance after subarachnoid hemorrhage
46. Bedside detection of brain ischemia using intracerebral microdialysis: Subarachnoid hemorrhage and delayed ischemic deterioration
47. Current status of neuroprotection trials for traumatic brain injury: Lessons from animal models and clinical studies
48. The role of secondary brain injury in determining outcome from severe head injury
49. Endotracheal intubation in the field improves survival in patients with severe head injury
50. Significance of intracranial hypertension in severe head injury
51. Initial CT findings in 753 patients with severe head injury. A report from the NIH Traumatic Coma Data Bank
52. A clinical evaluation of the Camino subdural screw and ventricular monitoring kits
53. Furosemide- and mannitol-induced changes in intracranial pressure and serum osmolality and electrolytes
54. Effect of mannitol on increased intracranial pressure
55. Regional cerebral blood flow following resuscitation from hemorrhagic shock with hypertonic saline
56. Cerebral hemodynamic effects of 7.2% hypertonic saline in patients with head injury and raised intracranial pressure
57. The joint section on neurotrauma and critical care: Hyperventilation
58. A radnomized, double-blind study of phenytoin for the prevention of post-traumatic seizures
59. Disadvantages of prolonged neuromuscular blockade in patients with head injury
60. Propofol in the treatment of moderate and severe head injury: A randomized, prospective double-blinded pilot trial
61. Barbiturate control of intracranial hypertension in head injury and other conditions: Iatrogenic coma
62. The joint section on neurotrauma and critical care: Use of barbiturates in the control of intracranial hypertension
63. The joint section on neurotrauma and critical care: Role of steroids
64. Corticosteroids for acute traumatic brain injury
65. Clinical trials in traumatic brain injury: What can we learn from previous studies?
66. Craniocerebral trauma: Protection and retrieval of the neuronal population after injury
67. Lack of effect of induction of hypothermia after acute brain injury
68. The importance of brain temperature in cerebral injury
69. Cerebral perfusion pressure: Management protocol and clinical results
70. Improved outcome after severe head injury with a new therapy based on principles for brain volume regulation and preserved microcirculation
71. Continuous monitoring of cerebral oxygenation in acute brain injury: Assessment of cerebral hemodynamic reserve
72. Jugular venous desaturation and outcome after head injury
73. 2 to outcome after severe head injury
74. Comparison of brain tissue oxygen tension to microdialysis-based measures of cerebral ischemia in fatally head-injured humans
75. Extracellular lactate and glucose alterations in the brain after head injury measured by microdialysis
76. Acute regional cerebral blood flow changes caused by severe head injuries
77. The incidence and significance of hemostatic abnormalities in patients with head injuries
78. Trends in spinal cord injury demographics and treatment outcomes between 1973 and 1986
79. Combined medical and surgical treatment after acute spinal cord injury: Results of a prospective pilot study to assess the merits of aggressive medical resuscitation and blood pressure management
80. Diagnosis of cervical spine injury in motor vehicle crash victims: How many x-rays are enough?
81. Cervical spine trauma: How much more do we learn by routinely using helical CT?
82. Alteration of thromboxane and prostacyclin levels in experimental spinal cord injury
83. Alteration in extracellular amino acids after traumatic spinal cord injury
84. Potassium and calcium changes in injured spinal cords
85. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study
86. Effects of timing of methyl-prednisolone or naloxone administration on recovery of segmental and long-tract neurological function in NASCIS 2
87. Administration of Methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the third national acute spinal cord injury randomized controlled trial
88. Past and current clinical studies with GM-1 ganglioside in acute spinal cord injury
89. Recovery of motor function after spinal cord injury - A randomized, placebo-controlled trial with GM-1 ganglioside
90. The intercostal to phrenic nerve transfer: An effective means of reanimating the diaphragm in patients with high cervical spine injury
91. Prevention of thromboembolism in spinal cord injury
92. Recent trends in mortality and causes of death among persons with spinal cord injury
93. Fixed vs adjusted-dose heparin in the prophylaxis of thromboembolism in spinal cord injury
94. Prevention of thromboembolism after spinal cord injury using low-molecular-weight heparin
95. Deep vein thrombosis in spinal cord injury: Effect of prophylaxis with calf compression, aspirin, and dipyridamole
96. Mechanical plus pharmacological prophylaxis for deep vein thrombosis in acute spinal cord injury
97. Venous thrombosis and pulmonary embolism in spinal cord injury